Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact

Subscribe

Registers› Irish medicines ›Cipla Europe

Medicines register · Ireland

Cipla Europe — licensed medicines

11 medicines held by Cipla Europe on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 05 Oct 2026, 03:28 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Arquist 125 microgram per actuation pressurised inhalation, suspension PA1963/012/001

Fluticasone propionate

Not marketed

Arquist 250 microgram per actuation pressurised inhalation, suspension PA1963/012/002

Fluticasone propionate

Not marketed

Pirfenidone Cipla 267 mg Film-coated Tablets PA1963/016/001

Pirfenidone

Not marketed

Pirfenidone Cipla 801 mg Film-coated Tablets PA1963/016/002

Pirfenidone

Not marketed

Rivaroxaban Azure 10 mg film-coated tablets PA1963/019/002

Rivaroxaban

Not marketed

Rivaroxaban Azure 15 mg film-coated tablets PA1963/019/003

Rivaroxaban

Not marketed

Rivaroxaban Azure 15 mg film-coated tablets Rivaroxaban Azure 20 mg film-coated tablets PA1963/019/005

Rivaroxaban, Rivaroxaban

Not marketed

Rivaroxaban Azure 2.5 mg film-coated tablets PA1963/019/001

Rivaroxaban

Not marketed

Rivaroxaban Azure 20 mg film-coated tablets PA1963/019/004

Rivaroxaban

Not marketed

Teriparatide Cipla 20 micrograms/80 microliters solution for injection in pre-filled syringe PA1963/015/001

Teriparatide

Not marketed

Zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution PA1963/020/001

Ipratropium bromide monohydrate, Salbutamol

Not marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 5 October 2026. https://priyalifescience.com/medicines/company/cipla-europe

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.